Seegene's advanced technology for the simultaneous detection and quantification of multiple pathogens is both unique and superior, having already exceeded the capabilities of traditional diagnostic methods. This innovative approach allows for the concurrent identification of the causative agents of various infectious diseases, even in cases of co-infections, genetic variations, and varying levels of infection. Such capabilities are invaluable for the effective monitoring and management of patients' health conditions.

Simultaneous detection of multiple pathogens -

High sensitivity in multiple infection -

Quantification of each infected pathogens -

MuDT™ Technology represents a groundbreaking advancement in the simultaneous quantification and detection/discrimination of multiple targets within a single channel, eliminating the need for additional melting curve analysis post-amplification. This innovative technology addresses the increasing requirements for high multiplexing and quantification in a single assay, effectively overcoming the existing limitation of "One Channel, Only One Ct".

Seegene develops world's first multiplex MDx assays with it's AI system

Seegene has taken the lead in employing artificial intelligence to create multiplex molecular diagnostic kits. The company harnessed an AI system that integrates extensive data on pathogens and diseases, along with its proprietary algorithm, which automates the production of diagnostic reagents, thereby significantly shortening the development timeline.

By leveraging this artificial intelligence system, Seegene has achieved the remarkable feat of developing molecular diagnostic assays within just four days.

Infectious Diseases

• HBV Detection Kit

• HCV Detection Kit

• HIV Detection Kit

• HSV 1&2 Detection Kit

• HCV Genotyping Kit